• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转铁蛋白受体的内吞命运受c-Abl激酶调控。

The Endocytic Fate of the Transferrin Receptor Is Regulated by c-Abl Kinase.

作者信息

Cao Hong, Schroeder Barbara, Chen Jing, Schott Micah B, McNiven Mark A

机构信息

From the Department of Biochemistry and Molecular Biology, Center for Basic Research in Digestive Diseases, and.

Department of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905.

出版信息

J Biol Chem. 2016 Aug 5;291(32):16424-37. doi: 10.1074/jbc.M116.724997. Epub 2016 May 24.

DOI:10.1074/jbc.M116.724997
PMID:27226592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4974358/
Abstract

Clathrin-mediated endocytosis of transferrin (Tf) and its cognate receptor (TfR1) is a central pathway supporting the uptake of trophic iron. It has generally been assumed that this is a constitutive process. However, we have reported that the non-receptor tyrosine kinase, Src, is activated by Tf to facilitate the internalization of the Tf-TfR1 ligand-receptor complex. As an extension of these findings, we have tested whether subsequent trafficking steps might be regulated by additional kinase-dependent cascades, and we observed a significant endocytic block by inhibiting c-Abl kinase by a variety of methods. Importantly, Tf internalization was reduced significantly in all of these cell models and could be restored by re-expression of WT c-Abl. Surprisingly, this attenuated Tf-TfR1 endocytosis was due to a substantial drop in both the surface and total cellular receptor levels. Additional studies with the LDL receptor showed a similar effect. Surprisingly, immunofluorescence microscopy of imatinib-treated cells revealed a marked colocalization of internalized TfR1 with late endosomes/lysosomes, whereas attenuating the lysosome function with several inhibitors reduced this receptor loss. Importantly, inhibition of c-Abl resulted in a striking redistribution of the chaperone Hsc70 from a diffuse cytosolic localization to an association with the TfR1 at the late endosome-lysosome. Pharmacological inhibition of Hsc70 ATPase activity in cultured cells by the drug VER155008 prevents this chaperone-receptor interaction, resulting in an accumulation of the TfR1 in the early endosome. Thus, inhibition of c-Abl minimizes receptor recycling pathways and results in chaperone-dependent trafficking of the TfR1 to the lysosome for degradation. These findings implicate a novel role for c-Abl and Hsc70 as an unexpected regulator of Hsc70-mediated transport of trophic receptor cargo between the early and late endosomal compartments.

摘要

网格蛋白介导的转铁蛋白(Tf)及其同源受体(TfR1)的内吞作用是支持营养性铁摄取的核心途径。一般认为这是一个组成性过程。然而,我们曾报道非受体酪氨酸激酶Src可被Tf激活,以促进Tf-TfR1配体-受体复合物的内化。作为这些发现的延伸,我们测试了后续的运输步骤是否可能受其他激酶依赖性级联反应的调节,并且我们通过多种方法抑制c-Abl激酶观察到了显著的内吞阻断。重要的是,在所有这些细胞模型中,Tf内化均显著降低,并且通过重新表达野生型c-Abl可使其恢复。令人惊讶的是,这种减弱的Tf-TfR1内吞作用是由于表面和总细胞受体水平均大幅下降所致。对低密度脂蛋白受体的进一步研究显示了类似的效果。令人惊讶的是,对伊马替尼处理的细胞进行免疫荧光显微镜检查发现,内化的TfR1与晚期内体/溶酶体有明显的共定位,而用几种抑制剂减弱溶酶体功能可减少这种受体损失。重要的是,抑制c-Abl导致伴侣蛋白Hsc70从弥漫性的胞质定位显著重新分布至晚期内体-溶酶体处与TfR1结合。药物VER155008对培养细胞中Hsc70 ATP酶活性的药理学抑制作用可阻止这种伴侣蛋白-受体相互作用,导致TfR1在早期内体中积累。因此,抑制c-Abl可使受体再循环途径最小化,并导致伴侣蛋白依赖性地将TfR1运输至溶酶体进行降解。这些发现暗示了c-Abl和Hsc70作为Hsc70介导的营养性受体货物在早期和晚期内体区室之间运输的意外调节因子的新作用。

相似文献

1
The Endocytic Fate of the Transferrin Receptor Is Regulated by c-Abl Kinase.转铁蛋白受体的内吞命运受c-Abl激酶调控。
J Biol Chem. 2016 Aug 5;291(32):16424-37. doi: 10.1074/jbc.M116.724997. Epub 2016 May 24.
2
Unconventional endocytosis and trafficking of transferrin receptor induced by iron.铁诱导的转铁蛋白受体的非经典内吞作用和转运。
Mol Biol Cell. 2021 Jan 15;32(2):98-108. doi: 10.1091/mbc.E20-02-0129. Epub 2020 Nov 25.
3
Transferrin-directed internalization and cycling of transferrin receptor 2.转铁蛋白受体 2 的转铁蛋白导向内化和循环。
Traffic. 2009 Oct;10(10):1488-501. doi: 10.1111/j.1600-0854.2009.00961.x. Epub 2009 Jul 6.
4
Dominant-interfering Hsc70 mutants disrupt multiple stages of the clathrin-coated vesicle cycle in vivo.显性干扰型热休克蛋白70(Hsc70)突变体在体内破坏网格蛋白包被囊泡循环的多个阶段。
J Cell Biol. 2001 Feb 5;152(3):607-20. doi: 10.1083/jcb.152.3.607.
5
Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.转铁蛋白受体2:配体诱导的稳定性及向再循环途径重定向的证据
Mol Biol Cell. 2007 Mar;18(3):743-54. doi: 10.1091/mbc.e06-09-0798. Epub 2006 Dec 20.
6
Transferrin receptor 2 mediates a biphasic pattern of transferrin uptake associated with ligand delivery to multivesicular bodies.转铁蛋白受体2介导与配体递送至多囊泡体相关的转铁蛋白摄取的双相模式。
Am J Physiol Cell Physiol. 2004 Dec;287(6):C1769-75. doi: 10.1152/ajpcell.00337.2004. Epub 2004 Aug 18.
7
Leucine zipper transcription factor-like 1 binds adaptor protein complex-1 and 2 and participates in trafficking of transferrin receptor 1.亮氨酸拉链转录因子样 1 结合衔接蛋白复合物 1 和 2,并参与转铁蛋白受体 1 的运输。
PLoS One. 2020 Jan 2;15(1):e0226298. doi: 10.1371/journal.pone.0226298. eCollection 2020.
8
Ferristatin II promotes degradation of transferrin receptor-1 in vitro and in vivo.铁抑素 II 在体外和体内促进转铁蛋白受体-1 的降解。
PLoS One. 2013 Jul 23;8(7):e70199. doi: 10.1371/journal.pone.0070199. Print 2013.
9
Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF.响应表皮生长因子(EGF)时,活化的表皮生长因子受体及其信号转导分子重新定位至早期内体下游的多泡小体。
Eur J Cell Biol. 2001 Apr;80(4):285-94. doi: 10.1078/0171-9335-00160.
10
The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells.转铁蛋白受体1和2在人肝癌细胞摄取转铁蛋白结合铁中的作用。
Am J Physiol Cell Physiol. 2009 Dec;297(6):C1567-75. doi: 10.1152/ajpcell.00649.2008. Epub 2009 Oct 14.

引用本文的文献

1
Targeting ferroptosis: a promising avenue for ovarian cancer treatment.靶向铁死亡:卵巢癌治疗的一条有前景的途径。
Front Immunol. 2025 Jun 5;16:1578723. doi: 10.3389/fimmu.2025.1578723. eCollection 2025.
2
Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer.利用HFn纳米偶联物将西妥昔单抗重新用于三阴性乳腺癌免疫治疗的双靶点策略。
ACS Appl Mater Interfaces. 2025 Jun 11;17(23):33648-33663. doi: 10.1021/acsami.5c06626. Epub 2025 May 6.
3
Organelle landscape analysis using a multiparametric particle-based method.利用基于多参数粒子的方法进行细胞器景观分析。
PLoS Biol. 2024 Sep 17;22(9):e3002777. doi: 10.1371/journal.pbio.3002777. eCollection 2024 Sep.
4
Ectopic expression of DOCK8 regulates lysosome-mediated pancreatic tumor cell invasion.DOCK8 的异位表达调节溶酶体介导线粒体肿瘤细胞侵袭。
Cell Rep. 2023 Sep 26;42(9):113042. doi: 10.1016/j.celrep.2023.113042. Epub 2023 Aug 30.
5
c-Abl Tyrosine Kinase Is Required for BDNF-Induced Dendritic Branching and Growth.c-Abl 酪氨酸激酶对于 BDNF 诱导的树突分支和生长是必需的。
Int J Mol Sci. 2023 Jan 18;24(3):1944. doi: 10.3390/ijms24031944.
6
Pseudokinase NRP1 facilitates endocytosis of transferrin in the African trypanosome.假激酶 NRP1 促进非洲锥虫转铁蛋白的内吞作用。
Sci Rep. 2022 Nov 3;12(1):18572. doi: 10.1038/s41598-022-22054-x.
7
Towards a translational physiologically-based pharmacokinetic (PBPK) model for receptor-mediated transcytosis of anti-transferrin receptor monoclonal antibodies in the central nervous system.构建用于抗转铁蛋白受体单克隆抗体在中枢神经系统中受体介导转胞吞作用的基于生理学的药代动力学(PBPK)转化模型。
J Pharmacokinet Pharmacodyn. 2022 Jun;49(3):337-362. doi: 10.1007/s10928-021-09800-w. Epub 2022 Jan 29.
8
Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis-Mechanistic Insights into Anemia of Inflammation and Its Treatment.铁稳态的生理学和炎症驱动病理生理学-炎症性贫血及其治疗的机制见解。
Nutrients. 2021 Oct 22;13(11):3732. doi: 10.3390/nu13113732.
9
Roquin is a major mediator of iron-regulated changes to transferrin receptor-1 mRNA stability.Roquin是铁调节转铁蛋白受体-1 mRNA稳定性变化的主要调节因子。
iScience. 2021 Mar 26;24(4):102360. doi: 10.1016/j.isci.2021.102360. eCollection 2021 Apr 23.
10
Human Corneal Epithelial Cells Internalize Aspergillus flavus Spores by Actin-Mediated Endocytosis.人角膜上皮细胞通过肌动蛋白介导的内吞作用内化黄曲霉孢子。
Infect Immun. 2021 May 17;89(6). doi: 10.1128/IAI.00794-20.

本文引用的文献

1
PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells.前蛋白转化酶枯草溶菌素9与低密度脂蛋白受体降解:循环系统及细胞中的调控机制
Curr Opin Lipidol. 2014 Oct;25(5):387-93. doi: 10.1097/MOL.0000000000000114.
2
Chaperone-mediated autophagy: roles in disease and aging.伴侣蛋白介导的自噬:在疾病和衰老中的作用。
Cell Res. 2014 Jan;24(1):92-104. doi: 10.1038/cr.2013.153. Epub 2013 Nov 26.
3
Functional analysis of Hsp70 inhibitors.Hsp70 抑制剂的功能分析。
PLoS One. 2013 Nov 12;8(11):e78443. doi: 10.1371/journal.pone.0078443. eCollection 2013.
4
Endocytosis of receptor tyrosine kinases.受体酪氨酸激酶的内吞作用。
Cold Spring Harb Perspect Biol. 2013 May 1;5(5):a017459. doi: 10.1101/cshperspect.a017459.
5
Membrane-associated RING-CH (MARCH) 8 mediates the ubiquitination and lysosomal degradation of the transferrin receptor.膜相关环指蛋白 8(MARCH8)介导转铁蛋白受体的泛素化和溶酶体降解。
J Cell Sci. 2013 Jul 1;126(Pt 13):2798-809. doi: 10.1242/jcs.119909. Epub 2013 Apr 19.
6
Explaining why Gleevec is a specific and potent inhibitor of Abl kinase.解释为什么格列卫是 Abl 激酶的一种特异性和强效抑制剂。
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1664-9. doi: 10.1073/pnas.1214330110. Epub 2013 Jan 14.
7
Cellular and molecular mechanisms of muscle atrophy.肌肉萎缩的细胞和分子机制。
Dis Model Mech. 2013 Jan;6(1):25-39. doi: 10.1242/dmm.010389.
8
AP-3 regulates PAR1 ubiquitin-independent MVB/lysosomal sorting via an ALIX-mediated pathway.AP-3 通过一种 ALIX 介导的途径调节 PAR1 泛素非依赖性 MVB/溶酶体分拣。
Mol Biol Cell. 2012 Sep;23(18):3612-23. doi: 10.1091/mbc.E12-03-0251. Epub 2012 Jul 25.
9
Getting active: protein sorting in endocytic recycling.积极行动:内吞体循环中的蛋白质分拣。
Nat Rev Mol Cell Biol. 2012 Apr 13;13(5):323-8. doi: 10.1038/nrm3332.
10
Autophagy: for better or for worse.自噬:好坏参半。
Cell Res. 2012 Jan;22(1):43-61. doi: 10.1038/cr.2011.152. Epub 2011 Sep 13.